Everything tagged "insurance brokers" across research, earnings, and macro.
4 articles
WTW delivered stronger margins, higher free cash flow, and improving segment mix in 2025 despite a reported revenue decline. The stock looks attractive for moderate-risk investors, with organic growth and portfolio moves supporting a Buy case.
Marsh & McLennan Companies, Inc. (MRSH) gains after a steady Q1 that met expectations and reinforced the company’s resilience. This deep-dive earnings analysis examines margin durability, segment performance, guidance tone, and why investors rewarded disciplined execution over flash.
Marsh & McLennan stands out as a high-quality professional services compounder with strong margins, recurring fee-based revenue, and multiple growth levers. The stock looks more like a reasonable buy on weakness than a bargain-basement value play.
Marsh & McLennan Companies, Inc. (MRSH) gains 1.2% after earnings meets expectations, with investors reacting positively to the latest quarterly results.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the Generator